Accurately Track Retinopathy Progression
With No Human Grading Needed
What is EyeMark?
EyeMark takes fully automated diabetic retinopathy analysis one step beyond imaging, grading and reporting. It is designed to automatically and accurately track disease progression from visit to visit to determine if a patient’s disease has increased, decreased or remained stable. This information augments the “refer/no refer” assessment that is available today and is valuable for disease management.How does EyeMark work?
A visiting patient is imaged by an eye care professional using a commercial fundus camera and the fundus images are input to EyeMark. The software automatically analyzes and grades the images (for current visit and all available previous visits), and issues a simple, quantitative report. The report shows a positive number (MA increase), negative number (MA decrease), or zero (no change). The flexible technology works with image quality common in everyday practice and with any imaging protocol.